Single Photon Emission Computed Tomography (SPECT) II-16
Applications of SPECT II-17
Commonly used Radioisotopes in SPECT Scans II-17
Therapeutic Radiopharmaceuticals II-17
Characteristics of Therapeutic Radiopharmaceuticals II-17
Commonly used Therapeutic Agents II-18
Major Isotopes and their Therapeutic Applications II-18
Radiopharmaceuticals for Thyroid Therapy II-18
Radiopharmaceuticals for Cancer Therapy II-18
Radiopharmaceuticals for Radiosynoviorthesis Therapy II-18
Radiopharmaceuticals for Bone Pain Palliation Therapy II-19
A Peek Into Key Therapeutic Radiopharmaceuticals in Research
Pipeline As of the Year 2007 II-19
Radiopharmacy: A Key Link in the Distribution Chain II-20
3. Regional Market Overview II-21
3a. The United States II-21
A.Market Analysis II-21
Outlook II-21
Industry Structure II-21
Production Scenario II-21
Dependence On Imports II-21
Regulatory Scenario II-22
Thorny Regulations Dampen Down New Product Development II-22
FDA's Antidote II-22
Radiopharmaceutical Reimbursement in the US: Who's Under
the Umbrella II-23
Diagnostic Radiopharmaceuticals Bundled As Supplies Under
Medicare Reimbursements II-23
CMS Proposed Packaging of Zevalin & Bexxar into Diagnostic
Radiopharmaceuticals Raises Eyebrows II-23
Implications II-23
Recommendations II-24
Changes in Medicare Reimbursements Vetoed II-24
CMS Proposes New HOPPS Guidelines for 2008 II-25
(i) Bundling Radiology Drugs and Services II-25
(ii) Payment for Therapeutic Radiopharmaceuticals II-25
(iii) PET/CT scans II-26
(IV) Cardiac CT and Coronary CTA Procedures II-26
(v) Conversion factor II-26
Reimbursement Issues for PET II-26
PET Clinical Applicati
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |